$AGIO Recent News Agios Presents Preclinical Dat
Post# of 145223
Posted On: 12/11/2013 12:32:40 PM
$AGIO Recent News
Agios Presents Preclinical Data from Lead Programs at ASH 8:00 p.m. Dec. 9, 2013 - benzinga.com
Health-Care Stocks: Where to Find Value 6:08 a.m. Nov. 12, 2013 - Barrons.com
Agios Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 6:46 p.m. Nov. 9, 2013 - Seeking Alpha
The New Science Behind Medical Investing 3:27 a.m. Oct. 19, 2013 - Barrons.com
Pipeline Progress at Agios Pharma - Analyst Blog 11:10 a.m. Sept. 24, 2013 - Zacks.com
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 4:44 a.m. Sept. 23, 2013 - benzinga.com
Patients Share DNA for Cures 8:46 p.m. Sept. 16, 2013 - WSJ.com
How High Will Bluebird Bio Fly? 1:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 3:32 p.m. Sept. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Packaged Goods Are Dead Money (8/28/13) 5:05 a.m. Aug. 29, 2013 - Seeking Alpha
Pound For Pound, Are Biotechs Still Worth Their Salt? 4:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Goldman Sachs Initiates Agios Pharmaceuticals with Buy on Emerging Leadership Position 8:22 a.m. Aug. 19, 2013 - benzinga.com
The New IPO Boom 2:46 p.m. Aug. 5, 2013 - Barrons.com
Agios Pharmaceuticals Closes Initial Public Offering, Underwriters Exercised Full Option 3:03 p.m. July 29, 2013 - benzinga.com
Agios Pharmaceuticals - Another Successful Public Offering Of A Biotech Company 2:34 p.m. July 29, 2013 - Seeking Alpha
Agios Advances Cancer Metabolism Collaboration with Celgene 8:17 a.m. Today - BusinessWire
Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting 7:00 p.m. Dec. 9, 2013 - BusinessWire
Agios Pharmaceuticals, Inc. [AGIO] to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Nov. 22, 2013 - GlobeNewswire
Flagship VentureLabs(TM) Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome 8:30 a.m. Nov. 21, 2013 - PR Newswire
Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results 8:00 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 6:30 a.m. Oct. 31, 2013 - BusinessWire
Flagship VentureLabs(TM) Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients 8:00 a.m. Oct. 22, 2013 - PR Newswire
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference 5:30 a.m. Oct. 18, 2013 - BusinessWire
Agios Pharmaceuticals Added to Russell 2000(R), 3000(R) and Global Indexes 5:30 a.m. Oct. 1, 2013 - BusinessWire
Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors 5:30 a.m. Sept. 26, 2013 - BusinessWire
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation 5:30 a.m. Sept. 23, 2013 - BusinessWire
Agios Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 7:00 a.m. Sept. 5, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism 8:07 a.m. Sept. 3, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer 4:30 a.m. Aug. 27, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on AGIO, EPZM, ONTX and XON 7:30 a.m. Aug. 26, 2013 - ACCESSWIRE
RDInvesting Provides Investors with Free In-Depth Equity Reports on AGIO, HUN, KALU and ONTX 8:01 a.m. Aug. 20, 2013 - ACCESSWIRE
Agios Pharmaceuticals Closes Initial Public Offering 4:00 p.m. July 29, 2013 - BusinessWire
Agios Presents Preclinical Data from Lead Programs at ASH 8:00 p.m. Dec. 9, 2013 - benzinga.com
Health-Care Stocks: Where to Find Value 6:08 a.m. Nov. 12, 2013 - Barrons.com
Agios Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 6:46 p.m. Nov. 9, 2013 - Seeking Alpha
The New Science Behind Medical Investing 3:27 a.m. Oct. 19, 2013 - Barrons.com
Pipeline Progress at Agios Pharma - Analyst Blog 11:10 a.m. Sept. 24, 2013 - Zacks.com
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 4:44 a.m. Sept. 23, 2013 - benzinga.com
Patients Share DNA for Cures 8:46 p.m. Sept. 16, 2013 - WSJ.com
How High Will Bluebird Bio Fly? 1:36 p.m. Sept. 12, 2013 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 3:32 p.m. Sept. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cramer's Mad Money - Packaged Goods Are Dead Money (8/28/13) 5:05 a.m. Aug. 29, 2013 - Seeking Alpha
Pound For Pound, Are Biotechs Still Worth Their Salt? 4:12 p.m. Aug. 23, 2013 - Investors Business Daily
UPDATE: Goldman Sachs Initiates Agios Pharmaceuticals with Buy on Emerging Leadership Position 8:22 a.m. Aug. 19, 2013 - benzinga.com
The New IPO Boom 2:46 p.m. Aug. 5, 2013 - Barrons.com
Agios Pharmaceuticals Closes Initial Public Offering, Underwriters Exercised Full Option 3:03 p.m. July 29, 2013 - benzinga.com
Agios Pharmaceuticals - Another Successful Public Offering Of A Biotech Company 2:34 p.m. July 29, 2013 - Seeking Alpha
Agios Advances Cancer Metabolism Collaboration with Celgene 8:17 a.m. Today - BusinessWire
Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting 7:00 p.m. Dec. 9, 2013 - BusinessWire
Agios Pharmaceuticals, Inc. [AGIO] to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Nov. 22, 2013 - GlobeNewswire
Flagship VentureLabs(TM) Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome 8:30 a.m. Nov. 21, 2013 - PR Newswire
Agios Pharmaceuticals to Present Preclinical Research at the 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results 8:00 a.m. Nov. 7, 2013 - BusinessWire
Agios Pharmaceuticals to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on November 7, 2013 6:30 a.m. Oct. 31, 2013 - BusinessWire
Flagship VentureLabs(TM) Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients 8:00 a.m. Oct. 22, 2013 - PR Newswire
Agios to Present IDH Program Insights at AACR-NCI-EORTC International Conference 5:30 a.m. Oct. 18, 2013 - BusinessWire
Agios Pharmaceuticals Added to Russell 2000(R), 3000(R) and Global Indexes 5:30 a.m. Oct. 1, 2013 - BusinessWire
Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors 5:30 a.m. Sept. 26, 2013 - BusinessWire
Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation 5:30 a.m. Sept. 23, 2013 - BusinessWire
Agios Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 7:00 a.m. Sept. 5, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
Agios Pharmaceuticals to Present New Research at the 12th International Congress of Inborn Errors of Metabolism 8:07 a.m. Sept. 3, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
Agios Pharmaceuticals Named 2014 World Economic Forum Technology Pioneer 4:30 a.m. Aug. 27, 2013 - BusinessWire
Wall Street Fundamentals Releases New In-Depth Stock Reports on AGIO, EPZM, ONTX and XON 7:30 a.m. Aug. 26, 2013 - ACCESSWIRE
RDInvesting Provides Investors with Free In-Depth Equity Reports on AGIO, HUN, KALU and ONTX 8:01 a.m. Aug. 20, 2013 - ACCESSWIRE
Agios Pharmaceuticals Closes Initial Public Offering 4:00 p.m. July 29, 2013 - BusinessWire
(0)
(0)